Beximco Pharmaceuticals PLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Bangladesh
- Registered address
- 126, Kathaldia, Tongi, Gazipur 1711, Bangladesh (BGD)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3008763868 · DUNS 731579053
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-03-30
- NAIDrug Quality Assurance2015-01-22
Drugs this plant is listed as making
10 distinct drugs across 27 products name this site in their FDA label.
- CarvedilolUnichem Pharmaceuticals (Usa), Inc.
- Cyproheptadine HydrochlorideUnichem Pharmaceuticals (Usa), Inc.
- eletriptan hydrobromideApnar Pharma LP
- flecainide acetateUnichem Pharmaceuticals (Usa), Inc.
- Metformin hydrochlorideUnichem Pharmaceuticals (Usa), Inc.
- MethocarbamolUnichem Pharmaceuticals (Usa), Inc.
- NadololBluePoint Laboratories
- nebivolol hydrochlorideApnar Pharma LP
- Sotalol Hydrochloride Tables AFUnichem Pharmaceuticals (Usa), Inc.
- Sotalol Hydrochloride Tablets AFUnichem Pharmaceuticals (Usa), Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.